Literature DB >> 12164590

Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study.

K Geraki1, M J Farquharson, D A Bradley.   

Abstract

An x-ray fluorescence system with a synchrotron radiation source was used to quantify the levels of iron, copper and zinc in breast tissue specimens. Healthy tissue and breast carcinomas were investigated as an aid to understanding the mechanisms of breast cancer and as a possible complementary diagnostic tool. Eighty samples were measured in total. Twenty samples were matched pairs, i.e. 20 tumour samples with 20 corresponding healthy tissue specimens taken at a distance from the tumour. The remaining 40 samples consisted of 20 excised tumours and 20 healthy specimens from breast reduction surgeries. The levels of the elements of interest were quantified via calibration models constructed using the XRF response from standard solutions. The statistical analysis of the results indicates elevation of the levels of all three trace elements in the tumours. The effect is more prominent for copper and zinc while the contrast between healthy and diseased tissue is enhanced when comparing the independent specimens rather than the paired samples. Specifically, the ratio of mean tumour to mean healthy concentration for iron was 1.6 for the paired samples and 2.7 for the non-paired samples. The ratios describing copper content were 3.1 for paired and 3.6 for non-paired samples while for zinc they were 2.4 and 4.4 respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164590     DOI: 10.1088/0031-9155/47/13/310

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  39 in total

1.  A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells.

Authors:  Fei Wang; Shumei Zhai; Xiaojun Liu; Liwen Li; Shirley Wu; Q Ping Dou; Bing Yan
Journal:  Cancer Lett       Date:  2010-10-29       Impact factor: 8.679

2.  X-ray colour imaging.

Authors:  R J Cernik; K H Khor; C Hansson
Journal:  J R Soc Interface       Date:  2008-04-06       Impact factor: 4.118

3.  Mammary gland zinc metabolism: regulation and dysregulation.

Authors:  Shannon L Kelleher; Young Ah Seo; Veronica Lopez
Journal:  Genes Nutr       Date:  2009-04-02       Impact factor: 5.523

Review 4.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

Review 5.  X-ray fluorescence imaging of metals and metalloids in biological systems.

Authors:  Run Zhang; Li Li; Yasmina Sultanbawa; Zhi Ping Xu
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

6.  First step toward the "fingerprinting" of brain tumors based on synchrotron radiation X-ray fluorescence and multiple discriminant analysis.

Authors:  Magdalena Szczerbowska-Boruchowska; Marek Lankosz; Dariusz Adamek
Journal:  J Biol Inorg Chem       Date:  2011-07-03       Impact factor: 3.358

7.  Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.

Authors:  JunGang Deng; Wei Chen; Hang Deng
Journal:  J Fluoresc       Date:  2016-08-03       Impact factor: 2.217

8.  ASSESSMENT OF ANIMAL MODELS AS SURROGATES FOR HUMAN TUMORS FROM THREE DIFFERENT ORGANS.

Authors:  Ibrahim O Farah; Zikri Arslan; Michelle Tucci; Hamed Benghuzzi; Joseph A Cameron
Journal:  Biomed Sci Instrum       Date:  2018-04

9.  Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues.

Authors:  A Banas; W M Kwiatek; K Banas; M Gajda; B Pawlicki; T Cichocki
Journal:  J Biol Inorg Chem       Date:  2010-05-25       Impact factor: 3.358

10.  Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells.

Authors:  Vesna Milacic; Peifu Jiao; Bin Zhang; Bing Yan; Q Ping Dou
Journal:  Int J Oncol       Date:  2009-12       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.